Medicare Enrolled
Dr. Mark Glodener, MD
Family Medicine · Alpharetta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glodener from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glodener?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glodener
Dr. Mark Glodener is a family medicine specialist in Alpharetta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Glodener performed 660 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Glodener received a total of $16,709 from 69 pharmaceutical and/or device companies across 790 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glodener is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 48% volume in GA
$16,709 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗660
Medicare services
Top 48% in GA for family medicine
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $52 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
175 | $70 | $250 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
82 | $3 | $14 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
63 | $121 | $132 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
38 | $7 | $66 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
26 | $9 | $60 |
| Injection, methylprednisolone acetate, 40 mg | 20 | $5 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $110 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
17 | $8 | $20 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
16 | $41 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,709
Total received (2018-2024)
Avg $2,387/year across 7 years
Top 1% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
790
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,254
2023
$1,720
2022
$1,641
2021
$3,692
2020
$2,157
2019
$2,429
2018
$2,816
Payments by company (2024)
ABBVIE INC.
$480
AstraZeneca Pharmaceuticals LP
$260
Lilly USA, LLC
$217
SANOFI-AVENTIS U.S. LLC
$180
Esperion Therapeutics, Inc.
$155
Takeda Pharmaceuticals U.S.A., Inc.
$155
Corium, LLC
$145
GlaxoSmithKline, LLC.
$127
Novo Nordisk Inc
$97
Exact Sciences Corporation
$74
Amgen Inc.
$47
Cranial Technologies, Inc
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Noven Therapeutics, LLC
$44
Dexcom, Inc.
$41
Tris Pharma Inc
$40
Paratek Pharmaceuticals, Inc.
$20
Abbott Laboratories
$19
Seqirus USA Inc
$18
Philips North America LLC
$15
Neos Therapeutics, LP
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,474
Lilly USA, LLC
$1,423
Biohaven Pharmaceuticals, Inc.
$1,227
SANOFI-AVENTIS U.S. LLC
$1,082
AstraZeneca Pharmaceuticals LP
$976
Amgen Inc.
$794
ABBVIE INC.
$790
GlaxoSmithKline, LLC.
$787
Takeda Pharmaceuticals U.S.A., Inc.
$727
PFIZER INC.
$653
Teva Pharmaceuticals USA, Inc.
$612
Amarin Pharma Inc.
$464
Kowa Pharmaceuticals America, Inc.
$405
Merck Sharp & Dohme Corporation
$325
Corium, LLC
$288
Supernus Pharmaceuticals, Inc.
$278
Allergan, Inc.
$276
AbbVie Inc.
$269
Allergan Inc.
$265
Inari Medical, Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$187
Novartis Pharmaceuticals Corporation
$167
Synergy Pharmaceuticals Inc
$163
Abbott Laboratories
$157
Shire North American Group Inc
$156
Esperion Therapeutics, Inc.
$155
CSL Behring
$149
Exact Sciences Corporation
$135
Dexcom, Inc.
$134
Gilead Sciences, Inc.
$134
Axsome Therapeutics, Inc.
$106
AbbVie, Inc.
$106
Upsher-Smith Laboratories LLC
$105
Cranial Technologies, Inc
$97
SANOFI PASTEUR INC.
$96
Mannkind Corporation
$91
Ultragenyx Pharmaceutical Inc.
$90
UPSHER-SMITH LABORATORIES LLC
$88
Noven Therapeutics, LLC
$80
ARBOR PHARMACEUTICALS, INC.
$76
MannKind Corporation
$64
Tris Pharma Inc
$58
Genentech USA, Inc.
$52
IBSA Pharma Inc.
$48
BioFire Diagnostics, LLC
$47
BioCryst US Sales Co., LLC
$45
Biohaven Pharmaceutical Holding Company Ltd.
$41
Ironshore Pharmaceuticals Inc.
$41
Circassia Pharmaceuticals Inc
$40
Eisai Inc.
$40
Pharming Healthcare, Inc.
$40
IDORSIA PHARMACEUTICALS US INC
$37
EISAI INC.
$36
Phadia US Inc.
$36
Seqirus USA Inc
$34
Merck Sharp & Dohme LLC
$33
Neos Therapeutics, LP
$32
Currax Pharmaceuticals LLC
$29
GENZYME CORPORATION
$23
Horizon Therapeutics plc
$23
Paratek Pharmaceuticals, Inc.
$20
Bausch Health US, LLC
$19
Ironwood Pharmaceuticals, Inc
$18
Philips North America LLC
$15
Arbor Pharmaceuticals, Inc.
$15
Sanofi Pasteur Inc.
$14
RedHill Biopharma Inc.
$13
kaleo, Inc.
$11
Mission Pharmacal Company
$11
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
(CK7) Extended Holter · AFREZZA · AIRSUPRA · AJOVY · APLENZIN · AREXVY · ASMANEX · AUVI-Q · AZSTARYS · Adzenys XR-ODT · Aimovig · Auvelity · Azstarys · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BOOSTRIX · BREO · BREZTRI · BYSTOLIC · Belviq · BioFire FilmArray · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Crysvita · Dayvigo · Dexcom G6 Transmitter · Doc Band · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · Evekeo · FARXIGA · FLECTOR · FLOWTRIEVER CATHETER · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · FreeStyle Libre 2 · Haegarda · Horizant · ImmunoCAP · JANUVIA · JARDIANCE · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LEQVIO · LICART · LINZESS · LIVALO · LYRICA · Livalo · MENACTRA · MENQUADFI · MOUNJARO · MYDAYIS · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · OFEV · ORLADEYO · Orladeyo · Otezla · Otovel · Ozempic · PENNSAID · PENTACEL · PNEUMOVAX 23 · POMPE - DISEASE · PREMARIN · PREVNAR 13 · PROCLAIM · Prednisolone 25 · Prolia · QELBREE · QULIPTA · QUVIVIQ · QVAR · REYVOW · ROTATEQ · RUCONEST · RYBELSUS · Repatha · Rybelsus · S · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · TZIELD · Talicia · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · VAXELIS · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Victoza · Vyvanse · Wegovy · Xelstrym · Xofluza · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
1,030
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
NORTHSIDE HOSPITAL CHEROKEE
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glodener is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glodener experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Glodener performed 204 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Glodener receive payments from pharmaceutical companies?
Yes. Dr. Glodener received a total of $16,709 from 69 companies across 790 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glodener's costs compare to other family medicine physicians in Alpharetta?
Dr. Glodener's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glodener) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Alpharetta
Browse family medicine physicians in Alpharetta ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology